CONTACTAbout UsCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
A two-step approach against HIV involving first flushing the virus out of hiding then killing it with a toxic antibody may offer the first hope for controlling a lifelong AIDS infection, U.S. researchers reported on Tuesday. The technique to locate and kill dormant HIV-infected immune system cells works in mice and is ready to test in monkeys, the team at the University of California, Los Angeles, said. The process wouldn't be a cure, but could allow people to take years or even decades off of the powerful drug cocktails that can keep the virus at bay, but which cause serious side-effects from diarrhea to heart disease. Writing in the September issue of the journal Immunity, lead researcher Jerome Zack and colleagues said they had devised a two-step system for first partially activating the cells the virus hides in, then killing the cells before the virus can escape. The cells they targeted are called resting T cells. When these cells are dormant, HIV drugs cannot find them and work against the virus hiding inside. "About one in a million T cells holds latent HIV that the antiretroviral drugs can't touch," said Zack. "In order to make it visible so you can attack it, you have to activate it." Attempts to activate these cells have failed in the past because fully activating all of a patient's T cells can create potentially deadly illness. Zack's team used two compounds to only partially activate the T cells. One, interleukin-7, is a naturally occurring compound. The other, called prostratin, comes from a tree native to the Pacific island of Samoa. "They hit a specific activation pathway but don't fully turn on cells," Zack said. At that point they introduce an antibody that specifically targets HIV-infected cells that is spliced to a piece of diphtheria toxin. "Because the antibody is linked to a toxin molecule, it pops into the cell," Zack said. "The toxin kills the cell before lots of viruses are made." The approach worked in mice, clearing 70% to 80% of the reservoir of latent T-cells without mistakenly attacking any healthy T cells. Zack envisions that the procedure would be used along with intermittent anti-HIV drug therapy to keep HIV from spreading in the body. Even then, he does not think it would offer a complete cure, but patients may be able to safely stop anti-HIV medications for years or even decades at a time once they achieve an undetectable level of virus in their bloodstream and then flush out the remaining HIV reservoir.
From our Sponsors
Most Popular
31 Period Films of Lesbians and Bi Women in Love That Will Take You Back
December 09 2024 1:00 PM
18 of the most batsh*t things N.C. Republican governor candidate Mark Robinson has said
October 30 2024 11:06 AM
True
After 20 years, and after tonight, Obama will no longer be the Democrats' top star
August 20 2024 12:28 PM
Trump ally Laura Loomer goes after Lindsey Graham: ‘We all know you’re gay’
September 13 2024 2:28 PM
Melania Trump cashed six-figure check to speak to gay Republicans at Mar-a-Lago
August 16 2024 5:57 PM
These 13 major companies caved to the far right and stopped DEI programs
January 24 2025 1:11 PM
True
Latest Stories
Donald Trump bans transgender athletes from playing sports
February 05 2025 4:15 PM
West Point military academy eliminates cadet clubs amid Trump’s diversity crackdown
February 05 2025 2:42 PM
15 Democratic state AGs stand by gender-affirming care
February 05 2025 2:39 PM
American satisfaction with state of LGBTQ+ rights reaches lowest point in over a decade
February 05 2025 2:05 PM
LGBTQ+ non-U.S. citizens at risk under Trump’s immigration crackdown: study
February 05 2025 12:56 PM
Lesbian cop wins $750k in sexual harassment lawsuit against former chief
February 05 2025 11:53 AM
If Trump can rename the Gulf, why can't we rename ourselves?
February 05 2025 7:00 AM
What can trans people do about Trump’s executive orders? Be plaintiffs, says Lambda Legal
February 05 2025 6:00 AM
Lawsuit challenges Trump's executive order targeting gender-affirming care
February 04 2025 7:58 PM
Fearless + Fighting Back: Lambda Legal’s plan to protect LGBTQ+ and HIV rights
February 04 2025 6:04 PM
e.l.f. Beauty CEO defends DEI: 'Our diversity is a key competitive advantage'
February 04 2025 5:19 PM
Trump moves to abolish Education Department amid push against 'wokeness'
February 04 2025 2:50 PM